Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2021.12.11
关于召开2022年第一次临时股东大会的通知公告
2021.12.11
关于向全资子公司天道医药（香港）有限公司增资的公告
2021.12.11
关于延长员工持股计划存续期的公告
2021.12.11
关于为面向专业投资者公开发行公司债券增加增信措施并 提供反担保的公告
2021.12.11
第五届董事会第十五次会议决议公告
2021.12.11
第五届监事会第八次会议决议公告
2021.12.02
第五届董事会第十四次会议决议公告
2021.11.26
关于参加2021深圳辖区“沟通传递价值，，，，交流创造良好 生态”上市公司投资者网上集体接待日...
2021.11.09
联合资信评估股份有限公司关于终止“16智信”信用等级的公告
2021.11.03
深圳市智信药业集团股份有限公司 “16智信”本息兑付及摘牌公告
第一页
上一页
19
20
21
22
23
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
站点地图
